What is Kromek Group PLC?
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets.
KMK · Verdict
Strong reward · moderate risk
KMK stands out on profitability and growth, but watch the volatility signal.
Based on 88% data coverage
KMK · Verdict
14% net margin · 25% ROE
Revenue +30.0% CAGR
Interest covered 2.7×
P/E 59.5×
59% free-cash-flow margin
Below average
Model-based scoring. For information only — not financial advice.
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company is listed on the LSE in UK, operating in the Technology sector, with a market capitalisation of 77.79M, and a P/E ratio of 5.9x.
The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.